190 related articles for article (PubMed ID: 33903709)
1. SARS-CoV-2 does not have a strong effect on the nasopharyngeal microbial composition.
Braun T; Halevi S; Hadar R; Efroni G; Glick Saar E; Keller N; Amir A; Amit S; Haberman Y
Sci Rep; 2021 Apr; 11(1):8922. PubMed ID: 33903709
[TBL] [Abstract][Full Text] [Related]
2. Metagenomic Next-Generation Sequencing of Nasopharyngeal Specimens Collected from Confirmed and Suspect COVID-19 Patients.
Mostafa HH; Fissel JA; Fanelli B; Bergman Y; Gniazdowski V; Dadlani M; Carroll KC; Colwell RR; Simner PJ
mBio; 2020 Nov; 11(6):. PubMed ID: 33219095
[TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 infection and viral load are associated with the upper respiratory tract microbiome.
Rosas-Salazar C; Kimura KS; Shilts MH; Strickland BA; Freeman MH; Wessinger BC; Gupta V; Brown HM; Rajagopala SV; Turner JH; Das SR
J Allergy Clin Immunol; 2021 Apr; 147(4):1226-1233.e2. PubMed ID: 33577896
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 Infection is Associated with Age- and Gender-Specific Changes in the Nasopharyngeal Microbiome.
Bozza S; Nunzi E; Frias-Mazuecos A; Pieraccini G; Pariano M; Renga G; Mencacci A; Talesa VN; Antognelli C; Puccetti P; Romani L; Costantini C
Front Biosci (Landmark Ed); 2024 Feb; 29(2):59. PubMed ID: 38420819
[TBL] [Abstract][Full Text] [Related]
5. Signatures of COVID-19 Severity and Immune Response in the Respiratory Tract Microbiome.
Merenstein C; Liang G; Whiteside SA; Cobián-Güemes AG; Merlino MS; Taylor LJ; Glascock A; Bittinger K; Tanes C; Graham-Wooten J; Khatib LA; Fitzgerald AS; Reddy S; Baxter AE; Giles JR; Oldridge DA; Meyer NJ; Wherry EJ; McGinniss JE; Bushman FD; Collman RG
mBio; 2021 Aug; 12(4):e0177721. PubMed ID: 34399607
[TBL] [Abstract][Full Text] [Related]
6. Metagenomic next-generation sequencing of nasopharyngeal microbiota in COVID-19 patients with different disease severities.
Aljabr W; Dandachi I; Abbas B; Karkashan A; Al-Amari A; AlShahrani D
Microbiol Spectr; 2024 May; 12(5):e0416623. PubMed ID: 38557102
[TBL] [Abstract][Full Text] [Related]
7. Nasopharyngeal Microbiome Signature in COVID-19 Positive Patients: Can We Definitively Get a Role to
Nardelli C; Gentile I; Setaro M; Di Domenico C; Pinchera B; Buonomo AR; Zappulo E; Scotto R; Scaglione GL; Castaldo G; Capoluongo E
Front Cell Infect Microbiol; 2021; 11():625581. PubMed ID: 33659220
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 infection reduces human nasopharyngeal commensal microbiome with inclusion of pathobionts.
Hoque MN; Sarkar MMH; Rahman MS; Akter S; Banu TA; Goswami B; Jahan I; Hossain MS; Shamsuzzaman AKM; Nafisa T; Molla MMA; Yeasmin M; Ghosh AK; Osman E; Alam SKS; Uzzaman MS; Habib MA; Mahmud ASM; Crandall KA; Islam T; Khan MS
Sci Rep; 2021 Dec; 11(1):24042. PubMed ID: 34911967
[TBL] [Abstract][Full Text] [Related]
9. Age-Related Changes in the Nasopharyngeal Microbiome Are Associated With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and Symptoms Among Children, Adolescents, and Young Adults.
Hurst JH; McCumber AW; Aquino JN; Rodriguez J; Heston SM; Lugo DJ; Rotta AT; Turner NA; Pfeiffer TS; Gurley TC; Moody MA; Denny TN; Rawls JF; Clark JS; Woods CW; Kelly MS
Clin Infect Dis; 2022 Aug; 75(1):e928-e937. PubMed ID: 35247047
[TBL] [Abstract][Full Text] [Related]
10. Alterations in the nasopharyngeal microbiome associated with SARS-CoV-2 infection status and disease severity.
Gauthier NPG; Locher K; MacDonald C; Chorlton SD; Charles M; Manges AR
PLoS One; 2022; 17(10):e0275815. PubMed ID: 36240246
[TBL] [Abstract][Full Text] [Related]
11. Oral Microbiome Alterations and SARS-CoV-2 Saliva Viral Load in Patients with COVID-19.
Miller EH; Annavajhala MK; Chong AM; Park H; Nobel YR; Soroush A; Blackett JW; Krigel A; Phipps MM; Freedberg DE; Zucker J; Sano ED; Uhlemann AC; Abrams JA
Microbiol Spectr; 2021 Oct; 9(2):e0005521. PubMed ID: 34643448
[TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2 on Ocular Surfaces in a Cohort of Patients With COVID-19 From the Lombardy Region, Italy.
Azzolini C; Donati S; Premi E; Baj A; Siracusa C; Genoni A; Grossi PA; Azzi L; Sessa F; Dentali F; Severgnini P; Minoja G; Cabrini L; Chiaravalli M; Veronesi G; Carcano G; Maffioli LS; Tagliabue A
JAMA Ophthalmol; 2021 Sep; 139(9):956-963. PubMed ID: 33662099
[TBL] [Abstract][Full Text] [Related]
13. NGS analysis of nasopharyngeal microbiota in SARS-CoV-2 positive patients during the first year of the pandemic in the Campania Region of Italy.
Giugliano R; Sellitto A; Ferravante C; Rocco T; D'Agostino Y; Alexandrova E; Lamberti J; Palumbo D; Galdiero M; Vaccaro E; Pagliano P; Weisz A; Giurato G; Franci G; Rizzo F
Microb Pathog; 2022 Apr; 165():105506. PubMed ID: 35358660
[TBL] [Abstract][Full Text] [Related]
14. The gut microbiome of COVID-19 recovered patients returns to uninfected status in a minority-dominated United States cohort.
Newsome RC; Gauthier J; Hernandez MC; Abraham GE; Robinson TO; Williams HB; Sloan M; Owings A; Laird H; Christian T; Pride Y; Wilson KJ; Hasan M; Parker A; Senitko M; Glover SC; Gharaibeh RZ; Jobin C
Gut Microbes; 2021; 13(1):1-15. PubMed ID: 34100340
[TBL] [Abstract][Full Text] [Related]
15. Nasopharyngeal microbiota profiling of pregnant women with SARS-CoV-2 infection.
Crovetto F; Selma-Royo M; Crispi F; Carbonetto B; Pascal R; Larroya M; Casas I; Tortajada M; Escudero N; Muñoz-Almagro C; Gomez-Roig MD; González-Torres P; Collado MC; Gratacos E
Sci Rep; 2022 Aug; 12(1):13404. PubMed ID: 35927569
[TBL] [Abstract][Full Text] [Related]
16. Super Dominant Pathobiontic Bacteria in the Nasopharyngeal Microbiota Cause Secondary Bacterial Infection in COVID-19 Patients.
Qin T; Wang Y; Deng J; Xu B; Zhu X; Wang J; Zhou H; Zhao N; Jin F; Ren H; Wang H; Li Q; Xu X; Guo Y; Li R; Xiong Y; Wang X; Guo J; Zheng H; Hou X; Wan K; Zhang J; Lu J; Kan B; Xu J
Microbiol Spectr; 2022 Jun; 10(3):e0195621. PubMed ID: 35579467
[TBL] [Abstract][Full Text] [Related]
17. The salivary and nasopharyngeal microbiomes are associated with SARS-CoV-2 infection and disease severity.
Kim JG; Zhang A; Rauseo AM; Goss CW; Mudd PA; O'Halloran JA; Wang L
J Med Virol; 2023 Feb; 95(2):e28445. PubMed ID: 36583481
[TBL] [Abstract][Full Text] [Related]
18. Nasopharyngeal microbiome reveals the prevalence of opportunistic pathogens in SARS-CoV-2 infected individuals and their association with host types.
Gupta A; Karyakarte R; Joshi S; Das R; Jani K; Shouche Y; Sharma A
Microbes Infect; 2022 Feb; 24(1):104880. PubMed ID: 34425246
[TBL] [Abstract][Full Text] [Related]
19. Exploring nasopharyngeal microbiota profile in children affected by SARS-CoV-2 infection.
Romani L; Del Chierico F; Pane S; Ristori MV; Pirona I; Guarrasi V; Cotugno N; Bernardi S; Lancella L; Perno CF; Rossi P; Villani A; Campana A; Palma P; Putignani L;
Microbiol Spectr; 2024 Mar; 12(3):e0300923. PubMed ID: 38289047
[TBL] [Abstract][Full Text] [Related]
20. Distinct systemic and mucosal immune responses during acute SARS-CoV-2 infection.
Smith N; Goncalves P; Charbit B; Grzelak L; Beretta M; Planchais C; Bruel T; Rouilly V; Bondet V; Hadjadj J; Yatim N; Pere H; Merkling SH; Ghozlane A; Kernéis S; Rieux-Laucat F; Terrier B; Schwartz O; Mouquet H; Duffy D; Di Santo JP
Nat Immunol; 2021 Nov; 22(11):1428-1439. PubMed ID: 34471264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
